Process View
Any process in which an organism modulates the frequency, rate or extent of its symbiont's transcription.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "modulation by host of symbiont transcription"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SP1 | Sp1 transcription factor | 0.999 | ||
| GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0.853 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.838 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.835 | ||
| JUN | jun proto-oncogene | 0.585 | ||
| CREBBP | CREB binding protein | 0.425 | Human | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.421 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.308 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.295 | ||
| ATF3 | activating transcription factor 3 | 0.257 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.255 | Human | |
| SMAD3 | SMAD family member 3 | 0.251 | ||
| SMAD4 | SMAD family member 4 | 0.249 | ||
| HDAC1 | histone deacetylase 1 | 0.244 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.236 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.228 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.213 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.213 | Human | |
| SOX10 | SRY (sex determining region Y)-box 10 | 0.210 | ||
| PAX3 | paired box 3 | 0.200 | ||
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.198 | ||
| ESR1 | estrogen receptor 1 | 0.160 | ||
| EP300 | E1A binding protein p300 | 0.150 | ||
| SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.141 | ||
| IER2 | immediate early response 2 | 0.135 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.101 | Human | |
| FOXD3 | forkhead box D3 | 0.098 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.094 | ||
| ARID1B | AT rich interactive domain 1B (SWI1-like) | 0.090 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.090 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.071 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.068 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.064 | ||
| KDM6A | lysine (K)-specific demethylase 6A | 0.063 | ||
| TBP | TATA box binding protein | 0.061 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.060 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.053 | ||
| SOX2 | SRY (sex determining region Y)-box 2 | 0.048 | ||
| YY1 | YY1 transcription factor | 0.045 | ||
| JUNB | jun B proto-oncogene | 0.040 | Human | |
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.040 | ||
| HDAC2 | histone deacetylase 2 | 0.036 | Human | |
| DDIT3 | DNA-damage-inducible transcript 3 | 0.035 | ||
| HMGA1 | high mobility group AT-hook 1 | 0.035 | Human | |
| CCL2 | chemokine (C-C motif) ligand 2 | 0.034 | Human | |
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.034 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.034 | ||
| HTT | huntingtin | 0.034 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.033 | ||
| RAB6A | RAB6A, member RAS oncogene family | 0.032 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.032 | Human | |
| CCR1 | chemokine (C-C motif) receptor 1 | 0.031 | ||
| IL10 | interleukin 10 | 0.030 | ||
| POU2F1 | POU class 2 homeobox 1 | 0.029 | Human | |
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.029 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.028 | Human | |
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.027 | ||
| OCIAD1 | OCIA domain containing 1 | 0.027 | ||
| IFNG | interferon, gamma | 0.027 | ||
| RPS6KA5 | ribosomal protein S6 kinase, 90kDa, polypeptide 5 | 0.026 | ||
| RAB14 | RAB14, member RAS oncogene family | 0.026 | ||
| SS18 | synovial sarcoma translocation, chromosome 18 | 0.025 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.022 | Human | |
| TCF4 | transcription factor 4 | 0.022 | ||
| RCOR1 | REST corepressor 1 | 0.022 | ||
| TAF13 | TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa | 0.022 | ||
| CALR | calreticulin | 0.022 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.021 | ||
| FPR3 | formyl peptide receptor 3 | 0.020 | ||
| PRMT6 | protein arginine methyltransferase 6 | 0.020 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.020 | ||
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.020 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.019 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.019 | ||
| RUNX3 | runt-related transcription factor 3 | 0.019 | ||
| ATF2 | activating transcription factor 2 | 0.019 | Human | |
| CYorf15A | chromosome Y open reading frame 15A | 0.019 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.019 | ||
| PSEN1 | presenilin 1 | 0.018 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.018 | ||
| ATF7IP | activating transcription factor 7 interacting protein | 0.017 | ||
| DARC | Duffy blood group, chemokine receptor | 0.017 | ||
| SLAMF8 | SLAM family member 8 | 0.017 | ||
| SKIL | SKI-like oncogene | 0.016 | ||
| AR | androgen receptor | 0.016 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.016 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.016 | Human | |
| IL2RB | interleukin 2 receptor, beta | 0.015 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.015 | ||
| TP53 | tumor protein p53 | 0.015 | ||
| SELE | selectin E | 0.014 | ||
| FOSL1 | FOS-like antigen 1 | 0.014 | ||
| TNF | tumor necrosis factor | 0.014 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.014 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.014 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.013 | ||
| DDX3Y | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked | 0.013 | ||
| IGF2BP1 | insulin-like growth factor 2 mRNA binding protein 1 | 0.013 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.013 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.013 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.013 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.013 | ||
| EGR1 | early growth response 1 | 0.013 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.013 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.012 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.012 | ||
| FUBP1 | far upstream element (FUSE) binding protein 1 | 0.012 | ||
| UBD | ubiquitin D | 0.012 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.012 | ||
| UTY | ubiquitously transcribed tetratricopeptide repeat gene, Y-linked | 0.012 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.012 | ||
| TAF4 | TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa | 0.012 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.012 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.012 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.012 | ||
| SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | 0.012 | ||
| CH25H | cholesterol 25-hydroxylase | 0.012 | ||
| HIC1 | hypermethylated in cancer 1 | 0.012 | ||
| EMD | emerin | 0.011 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.011 | ||
| GLTPD1 | glycolipid transfer protein domain containing 1 | 0.011 | ||
| JUND | jun D proto-oncogene | 0.011 | Human | |
| IRF2BP1 | interferon regulatory factor 2 binding protein 1 | 0.011 | ||
| NFYA | nuclear transcription factor Y, alpha | 0.011 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.011 | ||
| APTX | aprataxin | 0.011 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.011 | ||
| CD163 | CD163 molecule | 0.011 | ||
| PBRM1 | polybromo 1 | 0.011 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.010 | ||
| JDP2 | Jun dimerization protein 2 | 0.010 | ||
| IL1A | interleukin 1, alpha | 0.010 |